Novo Nordisk said 80% of U.S. patients with insurance coverage who take its highly popular weight loss treatment Wegovy are paying less than $25 a month for the drug.
The remarks suggest that many insured Americans don't have to shoulder the full cost of a monthly package of Wegovy, which has aof around $1,350. It also comes as many U.S. health insurers balk at the extreme cost of Wegovy and other obesity drugs while dropping them from their plans, even as demand for those treatments soar nationwide and outpace supply.
He estimated that about 50 million Americans with obesity could be eligible for Wegovy coverage under their health plans. Wegovy, for example, leads to 15% weight loss after 68 weeks, according to clinical trials on the drug.
Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk flags continued restrictions on Wegovy suppliesNovo Nordisk (NOVOb.CO) on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions on supplies of its hugely popular Wegovy weight-loss drug.
Source: Reuters - 🏆 2. / 97 Read more »
Wegovy Maker Novo Nordisk’s Profit Surges on Weight-Loss-Drug DemandDanish pharmaceutical giant says it will continue to restrict supply in the U.S. as it boosts production capacity
Source: WSJ - 🏆 98. / 63 Read more »
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk saysNovo Nordisk said its blockbuster weight-loss drug Wegovy could receive expanded approval from the U.S. Food and Drug Administration within six months.
Source: CNBC - 🏆 12. / 72 Read more »
Novo Nordisk to 'significantly' boost U.S. Wegovy doses next yearNovo Nordisk to 'significantly' boost U.S. Wegovy doses next year
Source: Investingcom - 🏆 450. / 53 Read more »
Exclusive: Novo hires FUJIFILM unit to help make Wegovy weight-loss drugNovo Nordisk (NOVOb.CO) has hired FUJIFILM Diosynth Biotechnologies to fill Wegovy injection pens, a source familiar with the matter told Reuters, as the Danish drugmaker scrambles to boost output of its hugely popular weight-loss drug.
Source: Reuters - 🏆 2. / 97 Read more »
Stock Selloff On Ozempic and Wegovy Fears is an Overreaction, Says Novo CEOThe drugmaker's chief does allow that snack food companies may suffer as more people take the medicines.
Source: MarketWatch - 🏆 3. / 97 Read more »